Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05746481
What this trial is testing

Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
Liza Villaruz, MD 3
Not applicableUnknownNCT01106937
What this trial is testing

Factor XIII and Pulmonary Embolism in Neurosurgical Patients

Who this might be right for
Brain TumorVascular LesionFactor XIII Deficiency+1 more
Ludwig-Maximilians - University of Munich 130
Not applicableLooking for participantsNCT06707519
What this trial is testing

NSCLC Liquid Biopsies and Exhaled VOC

Who this might be right for
Lung CancerCirculating Tumor DNA
St. Joseph's Healthcare Hamilton 210
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT01310036
What this trial is testing

Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 208
Not applicableLooking for participantsNCT07175077
What this trial is testing

7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)

Who this might be right for
Small-cell Lung CancerBrain Metastases
University of Missouri-Columbia 20
Early research (Phase 1)Ended earlyNCT00892801
What this trial is testing

Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Vanderbilt-Ingram Cancer Center 5
Testing effectiveness (Phase 2)UnknownNCT06224387
What this trial is testing

CTS2190 Phase I /II Clinical Study in Patients

Who this might be right for
Solid TumorsPancreatic CancerNon-small Cell Lung Cancer+1 more
CytosinLab Therapeutics Co., Ltd. 224
Testing effectiveness (Phase 2)Ended earlyNCT01631279
What this trial is testing

A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Proacta, Incorporated 33
Not applicableActive Not RecruitingNCT06494241
What this trial is testing

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

Who this might be right for
Carcinoma, Non-Small-Cell LungLung NeoplasmsRespiratory Tract Neoplasms+7 more
AstraZeneca 1,000
Not applicableUnknownNCT05068869
What this trial is testing

Digital Outpatient Services

Who this might be right for
EpilepsyCancerInterstitial Lung Disease+1 more
Oslo University Hospital 180
Very early researchEnded earlyNCT00253461
What this trial is testing

11C Topotecan PET Imaging

Who this might be right for
Lung CancerMetastatic CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT04716946
What this trial is testing

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Who this might be right for
NSCLCNon-small Cell Lung CancerLung Cancer+5 more
Memorial Sloan Kettering Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT03513666
What this trial is testing

Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment

Who this might be right for
NSCLC
Shanghai Junshi Bioscience Co., Ltd. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05882513
What this trial is testing

Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer

Who this might be right for
NSCLCNeoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 36
Not applicableStudy completedNCT04879927
What this trial is testing

Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement

Who this might be right for
Breast CancerLung CancerGastrointestinal Cancer
Dana-Farber Cancer Institute 125
Early research (Phase 1)Study completedNCT04200417
What this trial is testing

Chemoembolization for Lung Tumors

Who this might be right for
Lung MetastasesEndobronchial MetastasesPleural Metastases+1 more
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06456138
What this trial is testing

Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC

Who this might be right for
KRAS Mutation-Related TumorsAdvanced Lung CancerRefractory Tumor
Shanghai Chest Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03717155
What this trial is testing

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

Who this might be right for
Squamous Non-Small Cell Lung Cancer
Merck KGaA, Darmstadt, Germany 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705074
What this trial is testing

FAPI PET Imaging - An Exploratory Study

Who this might be right for
Thyroid PathologyHead and Neck Cancer (H&N)Sinonasal Tract Tumor+14 more
Martin Huellner 770
Next Page